Afuco™ Anti-Human PTN ADCC Therapeutic Antibody, ADCC Enhanced

Anti-PTN ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-PTN antibodies functionally inhibit or block the angiogenic and oncogenic activities of PTN, and have great therapeutic value for detect cancer at an early stage and monitor tumor recurrence.
Supplier Creative Biolabs
Product # AFC-693CL
Pricing Inquiry
Host Human
Target PTN
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Feedback